The bovine atp-binding cassette transporter abcg2 tyr581ser single-nucleotide polymorphism increases milk secretion of the fluoroquinolone danofloxacin

Drug Metabolism and Disposition

Volumn 41, Issue 3, 2013, Pages 546-549

  Merino, Gracia ^a  

^a UNIVERSITY OF LEÓN   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER RESISTANCE PROTEIN; DANOFLOXACIN;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; COW; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG MILK LEVEL; FEMALE; GENOTYPE; HETEROZYGOTE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HOMOZYGOTE; IN VIVO STUDY; MEAN RESIDENCE TIME; NONHUMAN; PHARMACOGENETICS; PRIORITY JOURNAL; SINGLE DRUG DOSE; SINGLE NUCLEOTIDE POLYMORPHISM; TIME TO MAXIMUM PLASMA CONCENTRATION;

ANIMALS; ANTI-BACTERIAL AGENTS; AREA UNDER CURVE; ATP-BINDING CASSETTE TRANSPORTERS; CATTLE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; FLUOROQUINOLONES; FOOD CONTAMINATION; HALF-LIFE; HETEROZYGOTE; HOMOZYGOTE; INJECTIONS, INTRAMUSCULAR; LACTATION; METABOLIC CLEARANCE RATE; MILK; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84874056462     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.112.049056     Document Type: Article

References (30)

1. Adkison KK, Vaidya SS, Lee DY, Koo SH, Li L, Mehta AA, Gross AS, Polli JW, Lou Y, and Lee EJ (2008) The ABCG2 C421A polymorphism does not affect oral nitrofurantoin pharmacokinetics in healthy Chinese male subjects. Br J Clin Pharmacol 66:233-239.
2. Cohen-Zinder M, Seroussi E, Larkin DM, Loor JJ, Everts-van der Wind A, Lee JH, Drackley JK, Band MR, Hernandez AG, and Shani M, et al. (2005) Identification of a missense mutation inthe bovine ABCG2 gene with a major effect on the QTL on chromosome 6 affecting milk yield and composition in Holstein cattle. Genome Res 15:936-944.
3. Escudero E, Cárceles CM, Fernandez-Varon E, Marin P, and Benchaoui H (2007) Pharmacokinetics of danofloxacin 18% in lactating sheep and goats. J Vet Pharmacol Ther 30: 572-577.
4. European Commission (1986). Council Directive 86/609/EEC of 24 November 1986 on the approximation of laws, regulations and administrative provisions of the Member States regarding the protection of animals used for experimental and other scientific purposes. Official Journal L358.
5. Garcia MA, Solans C, Aramayona JJ, Rueda S, and Bregante MA (2000) Development of a method for the determination of danofloxacin in plasma by HPLC with fluorescence detection. Biomed Chromatogr 14:89-92.
6. Jonker JW, Merino G, Musters S, van Herwaarden AE, Bolscher E, Wagenaar E, Mesman E, Dale TC, and Schinkel AH (2005) The breast cancer resistance protein BCRP (ABCG2) concentrates drugs and carcinogenic xenotoxins into milk. Nat Med 11:127-129.
7. Jonker JW, Musters S, Vlaming ML, Plösch T, Gooijert KE, Hillebrand MJ, Rosing H, Beijnen JH, Verkade HJ, and Schinkel AH (2007) Breast cancer resistance protein (Bcrp1/Abcg2) is expressed in the harderian gland and mediates transport of conjugated protoporphyrin IX. Am J Physiol Cell Physiol 292:C2204-C2212.
8. Keskitalo JE, Pasanen MK, Neuvonen PJ, and Niemi M (2009) Different effects of the ABCG2 c.421C.A SNP on the pharmacokinetics of fluvastatin, pravastatin and simvastatin. Pharmacogenomics 10:1617-1624.
9. Kim HS, Sunwoo YE, Ryu JY, Kang HJ, Jung HE, Song IS, Kim EY, Shim JC, Shon JH, and Shin JG (2007) The effect of ABCG2 V12M, Q141K and Q126X, known functional variants in vitro, on the disposition of lamivudine. Br J Clin Pharmacol 64:645-654.
10. Komisarek J and Dorynek Z (2009) Effect of ABCG2, PPARGC1A, OLR1 and SCD1 gene polymorphism on estimated breeding values for functional and production traits in Polish Holstein-Friesian bulls. J Appl Genet 50:125-132.
11. McManaman JL and Neville MC (2003) Mammary physiology and milk secretion. Adv Drug Deliv Rev 55:629-641.
12. Merino G, Real R, Baro MF, Gonzalez-Lobato L, Prieto JG, Alvarez AI, and Marques MM (2009) Natural allelic variants of bovine ATP-binding cassette transporter ABCG2: increased activity of the Ser581 variant and development of tools for the discovery of new ABCG2 inhibitors. Drug Metab Dispos 37:5-9.
13. Morisaki K, Robey RW, Ozvegy-Laczka C, Honjo Y, Polgar O, Steadman K, Sarkadi B, and Bates SE (2005) Single nucleotide polymorphisms modify the transporter activity of ABCG2. Cancer Chemother Pharmacol 56:161-172.
14. Ni Z, Bikadi Z, Rosenberg MF, and Mao Q (2010) Structure and function of the human breast cancer resistance protein (BCRP/ABCG2). Curr Drug Metab 11:603-617.
15. Normanno G, Firinu A, Virgilio S, Mula G, Dambrosio A, Poggiu A, Decastelli L, Mioni R, Scuota S, and Bolzoni G, et al. (2005) Coagulase-positive Staphylococci and Staphylococcus aureus in food products marketed in Italy. Int J Food Microbiol 98:73-79.
16. Poutrel B, Stegemann MR, Roy O, Pothier F, Tilt N, and Payne-Johnson M (2008) Evaluation of the efficacy of systemic danofloxacin in the treatment of induced acute Escherichia coli bovine mastitis. J Dairy Res 75:310-318.
17. Real R, Egido E, Pérez M, González-Lobato L, Barrera B, Prieto JG, Alvarez AI, and Merino G (2011b) Involvement of breast cancer resistance protein (BCRP/ABCG2) in the secretion of danofloxacin into milk: interaction with ivermectin. J Vet Pharmacol Ther 34:313-321.
18. Real R, González-Lobato L, Baro MF, Valbuena S, de la Fuente A, Prieto JG, Alvarez AI, Marques MM, and Merino G (2011a) Analysis of the effect of the bovine adenosine triphosphate-binding cassette transporter G2 single nucleotide polymorphism Y581S on transcellular transport of veterinary drugs using new cell culture models. J Anim Sci 89: 4325-4338.
19. Roca M, Castillo M, Marti P, Althaus RL, and Molina MP (2010) Effect of heating on the stability of quinolones in milk. J Agric Food Chem 58:5427-5431.
20. Ron M, Cohen-Zinder M, Peter C, Weller JI, and Erhardt G (2006) Short communication: a polymorphism in ABCG2 in Bos indicus and Bos taurus cattle breeds. J Dairy Sci 89:4921-4923.
21. Schrickx JA and Fink-Gremmels J (2008) Implications of ABC transporters on the disposition of typical veterinary medicinal products. Eur J Pharmacol 585:510-519.
22. Shem-Tov M, Rav-Hon O, Ziv G, Lavi E, Glickman A, and Saran A (1998) Pharmacokinetics and penetration of danofloxacin from the blood into the milk of cows. J Vet Pharmacol Ther 21:209-213.
23. Shojaee Aliabadi F and Lees P (2003) Pharmacokinetic-pharmacodynamic integration of danofloxacin in the calf. Res Vet Sci 74:247-259.
24. van Herwaarden AE and Schinkel AH (2006) The function of breast cancer resistance protein in epithelial barriers, stem cells and milk secretion of drugs and xenotoxins. Trends Pharmacol Sci 27:10-16.
25. van Herwaarden AE, Wagenaar E, Merino G, Jonker JW, Rosing H, Beijnen JH, and Schinkel AH (2007) Multidrug transporter ABCG2/breast cancer resistance protein secretes riboflavin (vitamin B2) into milk. Mol Cell Biol 27:1247-1253.
26. Vlaming ML, Lagas JS, and Schinkel AH (2009) Physiological and pharmacological roles of ABCG2 (BCRP): recent findings in Abcg2 knockout mice. Adv Drug Deliv Rev 61:14-25.
27. Walsh PS, Metzger DA, and Higuchi R (1991) Chelex 100 as a medium for simple extraction of DNA for PCR-based typing from forensic material. Biotechniques 10:506-513.
28. Weikard R, Widmann P, Buitkamp J, Emmerling R, and Kuehn C (2012) Revisiting the quantitative trait loci for milk production traits on BTA6. Anim Genet 43:318-323.
29. Woodward OM, Köttgen A, Coresh J, Boerwinkle E, Guggino WB, and Köttgen M (2009) Identification of a urate transporter, ABCG2, with a common functional polymorphism causing gout. Proc Natl Acad Sci USA 106:10338-10342.
30. Zhou L, Naraharisetti SB, Wang H, Unadkat JD, Hebert MF, and Mao Q (2008) The breast cancer resistance protein (Bcrp1/Abcg2) limits fetal distribution of glyburide in the pregnant mouse: an Obstetric-Fetal Pharmacology Research Unit Network and University of Washington Specialized Center of Research Study. Mol Pharmacol 73:949-959.